Gibson Dunn has advised Avere Therapeutics. Sidley Austin has advised NextCure. Avere Therapeutics, Inc., a privately-held biotechnology company, and NextCure, Inc. (Nasdaq:NXTC), a clinical-stage biopharmaceutical company,...
Avere Therapeutics and NextCure Announce Merger with $320 Million Private Placement
Tractor Supply Company Acquires VIP Petcare from PetIQ
Sidley Austin has advised Tractor Supply Company. Davis Polk have advised Bansk Group and PetIQ. Tractor Supply Company (NASDAQ: TSCO), the largest rural lifestyle retailer in...
MacroGenics Sells GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Sidley has advised MacroGenics, Inc. MacroGenics, Inc. (“Bora” or “Bora Group”; TWSE: 6472; OTCQX: BORAY), a biopharmaceutical company focused on the development of antibody-based therapies for...
Presidio Investment Holdings and EQV Ventures Acquisition Corp. Announce US$660 Million Business Combination
Sidley Austin and Weil, Gotshal & Manges has advised Presidio Investment Holdings, while Kirkland & Ellis LLP has advised EQV Ventures Acquisition Corp. Baker Botts L.L.P....
Vultr’s $333 Million Financing Round
Sidley Austin represented LuminArx Capital Management in the transaction. LuminArx Capital Management (“LuminArx”) announced its equity financing with AMD of Vultr (“Vultr”), the world’s largest privately...